Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the AmoyDx® Pan Lung Cancer PCR Panel
Remote Patient Monitoring market will reach $760m by 2030 – Pharmaceutical Technology
Remote Patient Monitoring (RPM) devices are set to grow. Credit: Getty / martin-dm A new report by GlobalData has found that Remote Patient Monitoring (RPM)